Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Gyrodyne, LLC

Ticker
GYRO
Sector
Industry
Report date
November 14, 2026
Valye AI Score

94

Very high visibility
Recent developments
Recent developments summary

Recent developments include the company reporting preliminary net assets in liquidation of approximately $10.75 per share and ongoing ownership changes among institutional investors. The company continues to manage legal and operational challenges related to its liquidation plan.

Recent developments:
  • Gyrodyne reported preliminary net assets in liquidation of approximately $10.75 per share as of November 2026 [N1].
  • MFP Investors owned 3.70% of Gyrodyne as of February 2023 [N2].
  • Grantham, Mayo, Van Otterloo & Co. reduced its stake in Gyrodyne in February 2023 [N3].
  • The company has scheduled ex-dividend dates in prior years, indicating historical dividend activity [N4, N8].
Overview

Gyrodyne, LLC operates as a real estate holding and management company focused on medical office and industrial properties in New York State. Its portfolio includes properties in Suffolk County (Flowerfield) and Westchester County (Cortlandt Manor). The company’s strategy centers on pursuing entitlements to increase development flexibility and enhance lease values to maximize property values. Gyrodyne plans to liquidate its assets and dissolve after settling liabilities and distributing proceeds to shareholders. The company is involved in legal proceedings challenging subdivision approvals but has defended these successfully to date. It has entered into conditional sale agreements for portions of its properties and continues to market remaining assets. The company’s operations are currently managed by a single full-time executive, with retention incentives in place. Financially, Gyrodyne reported modest revenue and net losses in prior years and held cash reserves as of late 2026.

Executive summary

Gyrodyne, LLC is a New York-based limited liability company managing a portfolio of medical office and industrial properties in Suffolk and Westchester Counties. The company’s primary business strategy is to enhance property values through entitlement efforts and lease value improvements, with the goal of liquidating assets and dissolving the company. As of September 30, 2026, Gyrodyne held approximately $3.35 million in cash and cash equivalents. The company reported revenue of $1.83 million and a net loss of $2.5 million for fiscal year 2015. Gyrodyne is engaged in ongoing legal proceedings related to property subdivision approvals and is actively marketing its properties for sale, including a significant parcel under a conditional purchase agreement. The company’s CEO is the sole full-time employee following recent executive departures, with retention plans in place. Risks include management concentration, legal and regulatory uncertainties, financing challenges, and potential delays in asset sales. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for GYRO

Bull case model:

The company’s pursuit of entitlements and subdivision approvals could increase development flexibility and property values, potentially enhancing proceeds from asset sales. Successful resolution of legal challenges and completion of sales agreements could enable timely liquidation and distributions to shareholders. Retention of key management and securing financing to support operations through liquidation could facilitate execution of the strategic plan.

Bear case model:

Legal challenges to subdivision approvals and delays in obtaining necessary permits could extend the liquidation timeline and increase costs. Failure to secure financing or retain key management personnel could impair the company’s ability to manage the liquidation process effectively. Market conditions and buyer interest may limit sale prices or delay transactions, reducing distributions to shareholders. Increased debt service costs could constrain cash available for operations and entitlement efforts.

Moat:

Gyrodyne’s moat is limited given its business model as a real estate holding and liquidation company rather than an operating business with recurring revenue streams or proprietary assets. Its value depends largely on the underlying real estate portfolio and the success of entitlement and sale processes. The company’s ability to enhance property values through entitlements and manage legal and regulatory risks contributes to its value preservation. However, the absence of diversified operations and reliance on a small management team limit competitive advantages.

Risks overview
Risks summary
The concentration of management responsibility in a single executive combined with ongoing legal challenges and financing uncertainties represent the most significant risks to the company’s liquidation strategy and operational continuity.
Risks details:

• Management Concentration Risk: The company’s CEO is the sole full-time employee responsible for managing operations, entitlements, sales, and liquidation. Loss or unavailability of this individual could materially disrupt business execution.
• Legal and Regulatory Risks: Ongoing legal proceedings challenging subdivision approvals create uncertainty and potential delays in property sales and entitlement processes.
• Financing and Liquidity Risks: The company may require additional capital or loan modifications to fund operations through liquidation. Failure to secure financing could limit operational capacity and delay asset sales.
• Market and Sale Execution Risks: Real estate market conditions, buyer financing availability, and regulatory approvals affect the timing and pricing of property sales, impacting liquidation proceeds.
• Increased Debt Service Costs: The extension and interest rate reset on the Cortlandt Manor mortgage loan increase debt service obligations, reducing cash available for operations and entitlements.

FINAL FORECAST FOR GYRO

Final take one line
Gyrodyne operates as a real estate holding and liquidation company with a clear strategy to enhance property values through entitlements and to liquidate assets, facing execution risks from legal challenges, management concentration, and financing needs.
Final take 12 to 24 month view

Business trends: Focus on entitlement efforts to increase development flexibility and maximize property sale values amid ongoing legal proceedings.
Execution milestones: Completion of subdivision and site plan approvals, successful property sales, and management of liquidation process.
Key risks: Legal and regulatory uncertainties, reliance on key management personnel, financing challenges, and market conditions impacting asset sales.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

94
LLM visibility overview
LLM Visibility known facts
  • Gyrodyne, LLC is a limited liability company formed under New York law primarily managing a portfolio of medical office and industrial properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York [S1].
  • The company’s strategy focuses on enhancing property values through entitlement efforts to increase development flexibility and lease value enhancement, aiming to maximize shareholder returns [S1].
  • Gyrodyne intends to dissolve after disposing of all real property assets, settling debts, and distributing proceeds to common shareholders [S1].
  • The company’s real estate portfolio includes 13.8 acres in Cortlandt Manor with a 31,000 sq ft medical center and 63 acres in Flowerfield including a 14-acre industrial park with 135,000 rentable sq ft [S1].
  • The company is pursuing subdivision and site plan approvals for its properties, including a subdivision application for Flowerfield approved preliminarily in 2022 but subject to ongoing legal challenges under Article 78 proceedings [S1].
  • The Article 78 legal proceedings involve challenges to approvals but the company has successfully defended the Planning Board’s determinations with appeals ongoing [S1].
  • Gyrodyne has entered into a Purchase and Sale Agreement for a 49-acre parcel of Flowerfield to B2K Smithtown LLC with a purchase price range of $24 million to $28.74 million, contingent on subdivision and site plan approvals [S1].
  • The company is actively marketing remaining properties individually or combined and would consider acquisition offers for the company itself if value maximizing [S1].
  • As of September 30, 2026, Gyrodyne had cash and cash equivalents of approximately $3.35 million [S2].
  • The company reported revenue of approximately $1.83 million and a net loss of about $2.5 million for the fiscal year ended August 31, 2015 [S1].
  • The company’s CEO and CFO is Gary Fitlin, currently the only full-time employee after the COO’s departure in October 2026; retention programs are in place to motivate him [S2].
  • The company faces risks related to the loss of key management personnel, potential delays or failures in property sales, legal challenges, and financing uncertainties [S2].
  • The Cortlandt Manor mortgage loan maturity was extended to October 2031 with an increased interest rate of 7.28%, increasing debt service costs [S2].
  • The company reported preliminary net assets in liquidation of approximately $10.75 per share as of November 2026 [N1].
  • MFP Investors owns 3.70% of Gyrodyne as of February 2023 [N2].
  • Grantham, Mayo, Van Otterloo & Co. reduced its stake in Gyrodyne in February 2023 [N3].
  • The company has a history of ex-dividend dates scheduled in prior years, indicating prior dividend distributions [N4, N8].
Sources
Sources - Context summary

Generated 2026-11-15

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-27 | 10-K
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-11-06 | www.nasdaq.com | Gyrodyne, LLC Reports Preliminary Net Assets in Liquidation of approximately $10.75 per Share | https://www.nasdaq.com/articles/gyrodyne-llc-reports-preliminary-net-assets-liquidation-approximately-1075-share
  • N2 | 2023-02-14 | www.nasdaq.com | Mfp Investors Now Owns 3.70% of Gyrodyne (GYRO) | https://www.nasdaq.com/articles/mfp-investors-now-owns-3.70-of-gyrodyne-gyro
  • N3 | 2023-02-13 | www.nasdaq.com | Grantham, Mayo, Van Otterloo & Co. Cuts Stake in Gyrodyne (GYRO) | https://www.nasdaq.com/articles/grantham-mayo-van-otterloo-co.-cuts-stake-in-gyrodyne-gyro
  • N4 | 2016-06-15 | www.nasdaq.com | Gyrodyne , LLC (GYRO) Ex-Dividend Date Scheduled for June 16, 2016 | https://www.nasdaq.com/articles/gyrodyne-llc-gyro-ex-dividend-date-scheduled-june-16-2016-2016-06-15
  • N5 | 2015-12-30 | www.nasdaq.com | Michael Price Buys Shares in Plains GP Holdings, MSB Financial, Boardwalk Pipeline Partners | https://www.nasdaq.com/articles/michael-price-buys-shares-plains-gp-holdings-msb-financial-boardwalk-pipeline-partners
  • N6 | 2013-12-28 | www.nasdaq.com | Hold the Sizzle - Michael Price's Low P/E Stocks in Review | https://www.nasdaq.com/articles/hold-sizzle-michael-prices-low-pe-stocks-review-2013-12-28
  • N7 | 2013-10-28 | www.nasdaq.com | Billionaire Backers on a Shifting Sea of 52-Week Lows | https://www.nasdaq.com/articles/billionaire-backers-shifting-sea-52-week-lows-2013-10-28
  • N8 | 2012-12-13 | www.nasdaq.com | Gyrodyne Company of America, Inc. (GYRO) Ex-Dividend Date Scheduled for December 17, 2012 | https://www.nasdaq.com/articles/gyrodyne-company-america-inc-gyro-ex-dividend-date-scheduled-december-17-2012-2012-12-13
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine